Medtronic - 44 Year Stock Price History | MDT
- The all-time high Medtronic stock closing price was 122.32 on September 08, 2021.
- The Medtronic 52-week high stock price is 96.25, which is 8.2% above the current share price.
- The Medtronic 52-week low stock price is 75.96, which is 14.6% below the current share price.
- The average Medtronic stock price for the last 52 weeks is 85.46.
Medtronic Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 89.5086 | 80.2200 | 94.5000 | 79.8400 | 88.9800 | 11.39% |
2024 | 83.5156 | 80.8028 | 92.2700 | 76.2425 | 79.8800 | -0.59% |
2023 | 78.2674 | 73.8204 | 86.9518 | 67.1580 | 80.3542 | 9.61% |
2022 | 87.2511 | 97.0769 | 104.0854 | 71.1802 | 73.3111 | -22.55% |
2021 | 110.2252 | 103.9498 | 122.3230 | 90.5047 | 94.6522 | -9.81% |
2020 | 91.2371 | 100.2950 | 106.1957 | 63.8400 | 104.9533 | 5.67% |
2019 | 85.5325 | 75.3950 | 99.7988 | 70.7043 | 99.3232 | 27.33% |
2018 | 74.5701 | 69.3469 | 84.8436 | 64.5725 | 78.0019 | 14.51% |
2017 | 68.1128 | 58.5955 | 74.5488 | 58.5955 | 68.1153 | 15.23% |
2016 | 65.9798 | 61.5769 | 72.9873 | 59.0170 | 59.1100 | -5.44% |
2015 | 60.4393 | 57.2952 | 63.5402 | 52.1778 | 62.5115 | 8.62% |
2014 | 49.7351 | 44.7978 | 59.9861 | 41.9490 | 57.5502 | 28.13% |
2013 | 39.7758 | 32.0958 | 45.8264 | 32.0958 | 44.9152 | 42.88% |
2012 | 30.0663 | 28.7395 | 34.0243 | 26.9947 | 31.4367 | 10.64% |
2011 | 27.2025 | 27.0844 | 31.6486 | 22.4204 | 28.4126 | 5.81% |
2010 | 27.8852 | 31.0977 | 32.7540 | 22.4456 | 26.8527 | -13.81% |
2009 | 24.6346 | 22.6859 | 31.8061 | 16.9605 | 31.1544 | 42.53% |
2008 | 32.2572 | 33.8878 | 38.9537 | 19.8233 | 21.8581 | -36.33% |
2007 | 35.2660 | 35.6561 | 39.4246 | 30.9002 | 34.3282 | -5.22% |
2006 | 34.1301 | 38.8384 | 40.0389 | 28.6811 | 36.2179 | -6.29% |
2005 | 36.0647 | 32.9542 | 39.2681 | 32.5567 | 38.6504 | 16.72% |
2004 | 32.9126 | 32.1246 | 35.5209 | 30.8312 | 33.1142 | 2.68% |
2003 | 31.2635 | 30.7896 | 34.8261 | 28.4282 | 32.2507 | 7.23% |
2002 | 29.1887 | 32.7928 | 32.7928 | 22.1917 | 30.0772 | -10.35% |
2001 | 30.3254 | 38.8001 | 38.8001 | 25.5094 | 33.5478 | -14.80% |
2000 | 33.3988 | 22.2490 | 39.7782 | 22.2490 | 39.3739 | 66.33% |
1999 | 23.6230 | 23.6356 | 28.5367 | 20.2987 | 23.6716 | -1.49% |
1998 | 18.7938 | 16.1243 | 24.8100 | 14.7136 | 24.0303 | 42.11% |
1997 | 13.1392 | 10.7943 | 16.9102 | 9.3652 | 16.9102 | 55.23% |
1996 | 9.2064 | 8.2843 | 11.0346 | 7.5170 | 10.8936 | 22.37% |
1995 | 6.6574 | 4.2531 | 9.5397 | 4.2230 | 8.9024 | 101.79% |
1994 | 3.5164 | 3.2432 | 4.4117 | 2.7777 | 4.4117 | 36.94% |
1993 | 2.8081 | 3.6908 | 3.6908 | 2.0785 | 3.2217 | -13.04% |
1992 | 3.2614 | 3.5956 | 4.0257 | 2.4861 | 3.7048 | 1.94% |
1991 | 2.4105 | 1.6134 | 3.6343 | 1.5236 | 3.6343 | 119.73% |
1990 | 1.4372 | 1.2423 | 1.7547 | 1.1321 | 1.6540 | 32.89% |
1989 | 0.9900 | 0.7286 | 1.3252 | 0.7286 | 1.2446 | 71.39% |
1988 | 0.7650 | 0.8841 | 0.9212 | 0.6477 | 0.7262 | -15.76% |
1987 | 0.8314 | 0.7114 | 0.9969 | 0.6094 | 0.8621 | 21.78% |
1986 | 0.6574 | 0.3983 | 0.8380 | 0.3983 | 0.7079 | 76.71% |
1985 | 0.3147 | 0.2486 | 0.4052 | 0.2348 | 0.4006 | 61.14% |
1984 | 0.2782 | 0.3960 | 0.4006 | 0.2325 | 0.2486 | -34.96% |
1983 | 0.4502 | 0.4962 | 0.5456 | 0.3730 | 0.3822 | -22.60% |
1982 | 0.3867 | 0.3568 | 0.5157 | 0.3131 | 0.4938 | 39.73% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $115.624B | $32.364B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
Boston Scientific (BSX) | United States | $154.056B | 41.59 |
Stryker (SYK) | United States | $148.022B | 31.82 |
EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
Agilent Technologies (A) | United States | $38.594B | 25.57 |
ResMed (RMD) | United States | $33.728B | 25.98 |
Terumo (TRUMY) | Japan | $25.984B | 36.95 |
Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
Insulet (PODD) | United States | $19.908B | 85.13 |
Baxter (BAX) | United States | $17.948B | 12.94 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
Demant (WILYY) | Denmark | $8.092B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
ICU Medical (ICUI) | United States | $3.924B | 37.35 |
Envista Holdings (NVST) | United States | $3.683B | 29.30 |
Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
Haemonetics (HAE) | United States | $3.312B | 15.58 |
Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
Neogen (NEOG) | United States | $2.261B | 26.05 |
AtriCure (ATRC) | United States | $1.916B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
InMode (INMD) | Israel | $1.330B | 11.12 |
BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
CeriBell (CBLL) | United States | $0.911B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
Evolus (EOLS) | United States | $0.893B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
Valneva SE (VALN) | France | $0.635B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
Omeros (OMER) | United States | $0.503B | 0.00 |
Surmodics (SRDX) | United States | $0.501B | 0.00 |
Owens & Minor (OMI) | United States | $0.493B | 3.85 |
SNDL (SNDL) | Canada | $0.439B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
ZimVie (ZIMV) | United States | $0.368B | 30.98 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
Quanterix (QTRX) | United States | $0.311B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
Biote (BTMD) | United States | $0.252B | 5.52 |
Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
Zynex (ZYXI) | United States | $0.234B | 49.07 |
Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
High Tide (HITI) | Canada | $0.205B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
Brainsway (BWAY) | Israel | $0.184B | 97.80 |
TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
MacroGenics (MGNX) | United States | $0.166B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
Jin Medical (ZJYL) | China | $0.114B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
Fonar (FONR) | United States | $0.092B | 12.92 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Veru (VERU) | United States | $0.083B | 0.00 |
InterCure (INCR) | Israel | $0.076B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
Exagen (XGN) | United States | $0.063B | 0.00 |
Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
Apyx Medical (APYX) | United States | $0.054B | 0.00 |
Hongchang (HCIL) | China | $0.051B | 0.00 |
United-Guardian (UG) | United States | $0.046B | 13.24 |
ImmuCell (ICCC) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
INLIF (INLF) | $0.032B | 0.00 | |
Safety Shot (SHOT) | United States | $0.028B | 0.00 |
Nephros (NEPH) | United States | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |